Hydroxyurea for ß-thalassaemia major

The primary objective is to review the safety of hydroxyurea with regards to severe adverse effects in people with β-thalassaemia major.

The second objective is to review the efficacy of hydroxyurea in reducing or ameliorating the requirement of blood transfusions in people with β-thalassaemia major.

This is a protocol.

Share/Save